Damodar R. Kumbala
Damodar R. Kumbala has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Gift Echefu
Department of Cardiovascular Medicine, University of Tennessee Health Science Center, Memphis, TN, United States
2 shared publications - Ifeoluwa Stowe
Division of Nephrology , Beth Israel Deaconess Medical Center and Harvard Medical School , Boston , Massachusetts, USA , harvard.edu
2 shared publications - Alexandre M. Benjo
Lake Side Heart and Vascular Center, Lake Havasu, Arizona, USA
1 shared publication - Antonio Jimenez
Puerto Rico Vascular Center, Puerto Rico, USA
1 shared publication - Indranill Basu-Ray
Cardiologist and Interventional Electrophysiologist, Director of Cardiovascular Research, Director; Clinical Cardiology Electrophysiology Laboratory, Lt. Col. Luke Weathers, Jr. VA Medical Center; Adjunct Professor; School of Public Health, University of Memphis, Adjunct Associate Professor of Medicine (Cardiology) University of Tennessee Health Sciences Center, G 401 A, 4th floor, Bed Tower; 1030 Johnson Ave, Memphis, TN 38104
1 shared publication - Ivo Lukitsch
Department of Nephrology, Ochsner Health, New Orleans, Louisiana
1 shared publication
Latest Publications
- Open Access
- 1 January 2026
- Published by Wiley in Case Reports in Nephrology
- Vol. 2026 (1) , 9592129
Membranous Nephropathy Secondary to Syphilis
Membranous nephropathy (MN) is one of the most common causes of nephrotic syndrome in the adult population. Although the majority of the cases of MN are without any inciting event, about a third are caused or associated with immune diseases, infectious diseases, and drugs and toxins. There have been very few cases of association of syphilis and MN. We describe this rare infectious cause of MN in a 41‐year‐old patient who presented with nephrotic syndrome. The patient was diagnosed with secondary syphilis. He was treated successfully with complete resolution of his nephrotic picture. A thorough clinical history and physical examination which resulted in a suspicion for sexually transmitted disease led us to the successful diagnosis and treatment of this rare condition.
- 1 January 2026
- Published by Wiley in Case Reports in Nephrology
- Vol. 2026 (1) , 9592129
Open AccessMembranous Nephropathy Secondary to Syphilis
Membranous nephropathy (MN) is one of the most common causes of nephrotic syndrome in the adult population. Although the majority of the cases of MN are without any inciting event, about a third are caused or associated with immune diseases, infectious diseases, and drugs and toxins. There have been very few cases of association of syphilis and MN. We describe this rare infectious cause of MN in a 41‐year‐old patient who presented with nephrotic syndrome. The patient was diagnosed with secondary syphilis. He was treated successfully with complete resolution of his nephrotic picture. A thorough clinical history and physical examination which resulted in a suspicion for sexually transmitted disease led us to the successful diagnosis and treatment of this rare condition.
- Top Cited PapersOpen Access
- 29 September 2023
- Published by Frontiers Media SA in Frontiers in Nephrology
- Vol. 3, 1198560
Pathophysiological concepts and screening of cardiovascular disease in dialysis patients
Dialysis patients experience 10–20 times higher cardiovascular mortality than the general population. The high burden of both conventional and nontraditional risk factors attributable to loss of renal function can explain higher rates of cardiovascular disease (CVD) morbidity and death among dialysis patients. As renal function declines, uremic toxins accumulate in the blood and disrupt cell function, causing cardiovascular damage. Hemodialysis patients have many cardiovascular complications, including sudden cardiac death. Peritoneal dialysis puts dialysis patients with end-stage renal disease at increased risk of CVD complications and emergency hospitalization. The current standard of care in this population is based on observational data, which has a high potential for bias due to the paucity of dedicated randomized clinical trials. Furthermore, guidelines lack specific guidelines for these patients, often inferring them from non-dialysis patient trials. A crucial step in the prevention and treatment of CVD would be to gain better knowledge of the influence of these predisposing risk factors. This review highlights the current evidence regarding the influence of advanced chronic disease on the cardiovascular system in patients undergoing renal dialysis.
- 29 September 2023
- Published by Frontiers Media SA in Frontiers in Nephrology
- Vol. 3, 1198560
Top Cited PapersOpen AccessPathophysiological concepts and screening of cardiovascular disease in dialysis patients
Dialysis patients experience 10–20 times higher cardiovascular mortality than the general population. The high burden of both conventional and nontraditional risk factors attributable to loss of renal function can explain higher rates of cardiovascular disease (CVD) morbidity and death among dialysis patients. As renal function declines, uremic toxins accumulate in the blood and disrupt cell function, causing cardiovascular damage. Hemodialysis patients have many cardiovascular complications, including sudden cardiac death. Peritoneal dialysis puts dialysis patients with end-stage renal disease at increased risk of CVD complications and emergency hospitalization. The current standard of care in this population is based on observational data, which has a high potential for bias due to the paucity of dedicated randomized clinical trials. Furthermore, guidelines lack specific guidelines for these patients, often inferring them from non-dialysis patient trials. A crucial step in the prevention and treatment of CVD would be to gain better knowledge of the influence of these predisposing risk factors. This review highlights the current evidence regarding the influence of advanced chronic disease on the cardiovascular system in patients undergoing renal dialysis.
- Open Access
- 16 April 2022
- Published by Hindawi Limited in Case Reports in Vascular Medicine
- Vol. 2022, 1-6
Iatrogenic Fistula in Hemodialysis Patients: An Alternative Approach to Thrombectomy of Arteriovenous Graft (AVG) Thrombosis
Arterial venous (AV) fistula is the first choice of vascular access to perform hemodialysis in the vast majority of suitable patients followed by arteriovenous grafts (AVG). An iatrogenic fistula can occur when a second vein adjacent to the graft is punctured and the needle traverses the vein. In normal circumstances, this has no clinical repercussions and does not need correction, and in prior reports, it has helped to maintain the patency of partially occluded grafts but rarely can lead to thrombosis of the graft due to reduced flow and pressure in the graft lumen. We report here what we believe is a unique approach to perform thrombectomy of an occluded graft in a 71-year-old patient on hemodialysis to avoid placement of tunneled hemodialysis catheters and complications associated with catheters. When the outflow of basilic vein in this patient was thrombosed and could not be traversed, we successfully used an iatrogenic fistula as main outflow vein for the graft and created an alternative vein for drainage thus avoiding placement of a tunneled catheter for hemodialysis.
- 16 April 2022
- Published by Hindawi Limited in Case Reports in Vascular Medicine
- Vol. 2022, 1-6
Open AccessIatrogenic Fistula in Hemodialysis Patients: An Alternative Approach to Thrombectomy of Arteriovenous Graft (AVG) Thrombosis
Arterial venous (AV) fistula is the first choice of vascular access to perform hemodialysis in the vast majority of suitable patients followed by arteriovenous grafts (AVG). An iatrogenic fistula can occur when a second vein adjacent to the graft is punctured and the needle traverses the vein. In normal circumstances, this has no clinical repercussions and does not need correction, and in prior reports, it has helped to maintain the patency of partially occluded grafts but rarely can lead to thrombosis of the graft due to reduced flow and pressure in the graft lumen. We report here what we believe is a unique approach to perform thrombectomy of an occluded graft in a 71-year-old patient on hemodialysis to avoid placement of tunneled hemodialysis catheters and complications associated with catheters. When the outflow of basilic vein in this patient was thrombosed and could not be traversed, we successfully used an iatrogenic fistula as main outflow vein for the graft and created an alternative vein for drainage thus avoiding placement of a tunneled catheter for hemodialysis.